Immunology of endometriosis

Minerva Ginecologica

Volumn 57, Issue 3, 2005, Pages 237-248

  Ulukus, M ^a   Arici, A ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochines; Endometriossis; Immune system

Indexed keywords

AUTOANTIBODY; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOLOGY; MENSTRUATION DISORDER; NATURAL KILLER CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; REVIEW; STROMA CELL; T LYMPHOCYTE ACTIVATION; UTERUS CAVITY;

AUTOANTIBODIES; B-LYMPHOCYTES; CYTOKINES; ENDOMETRIOSIS; FEMALE; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 27144440872     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Snesky TE, Liu DT. Endometriosis: associations with menorrhagia, infertility, and oral contraceptives. Int J Gynaecol Obstet 1980;17:573-76.
2. Houston DE. Evidence for risk of pelvic endometriosis by age, race, and socioeconomic status. Epidemiol Rev 1984;6:167-91.
3. Cramer DW. Epidemiology of endometriosis in adolescent. In: Wilson EA, editor. Endometriosis. New York: Alan Liss;, 1987. p.: 5-8.
4. Sampson JA. Peritoneal endometriosis due to the menstruel dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-69.
5. Beyth Y, Yaffe H, Levij S, Sadovsky E. Retrograde seeding of endometrium: a sequela of tubal flushing. Fertil Steril 1975;26:1094-97.
6. Bartosik D, Jacobs SL, Kelly LJ. Endometrial tissue in peritoneal fluid. Fertil Steril 1986;46:796-800.
7. TeLinde RW, Scott RB. Experimental endometriosis. Am J Obstet Gynecol 1950;60:1147-73.
8. Ridley JH, Edwards IK. Experimental endometriosis in the human. Am J Obstet Gynecol 1958;76:783-90.
9. Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenic implications of the anatomic distribution. Obstet Gynecol 1986;67:335-38.
10. Melega C, Balducci M, Bulletti C, Galassi A, Jasonni VM, Flamigni C. Tissue factors influencing growth and maintenance of endometriosis. Ann N Y Acad Sci 1991; 622:256-65.
11. Hill JA, Paris HMP, Schiff I, and Anderson DJ. Characterization of leukocytes subpopulations in the peritoneal fluid of women with endometriosis. Fertil Steril 1988;50:2l6-22.
12. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995;12:32-34.
13. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-79.
14. Mayani A, Barel S, Soback S, Almagor M. Dioxin concentrations in women with endometriosis. Hum Reprod 1997;12:373-75.
15. Seli E, Arici A. Endometriosis: Interactions of immune and endocrine systems. Semin Reprod Med 2003;21: 135-44.
16. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune systeme in the development of endometriosis. Reprod Biol Endocrinol 2003;1:123.
17. Vinatier D, Dufour P. Is endometriosis an immunological disease? Contracept Fertil Sex 1997;25:179-91.
18. Iborra A, Palacio JR, Ulcova-Gallova Z, Martinez P. Autoimmune response in women with endometriosis. Am J Reprod Immunol 2000;44:236-41.
19. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001;76:223-31.
20. Halme J, Becker S, Haskill S. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984;148:85-90.
21. Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in the pathogenesis of endometriosis. Am J Obstet Gynecol 1987;156:783-89.
22. Dunselman GA, Hendrix MG, Bouckaert PX, Evers JL. Functional aspects of peritoneal macrophages in endometriosis of women. J Reprod Fertil 1988;82:707-10.
23. Olive DL, Weinberg JB, Haney AF. Peritoneal macrophages and infertility: the association between cell number and pelvic pathology. Fertil Steril 1985;44:772-77.
24. Lebovic DI, Mueller MD, Taylor RN. Immunbiology of endometriosis. Fertil Steril 2001;75:1-10.
25. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998;4:741-51.
26. Surrey ES, Hamle J. Effect of peritoneal fluid from endometriosis patients on endometrial stromal cell proliferation in vitro. Obstet Gynecol 1990;76:792-97.
27. Braun DP, Muriana A, Gebel H, Rotman C, Rana N, Dmowski WP. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994;61:78-84.
28. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa Mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the Mouse homologue of human CD68. Proc Natl Acad Sci USA 1995;92:9580-84.
29. Ottnad E, Parathasarathy S, Sambrano GR, Ramprasad MP, Quehenberger O, Kondratenko N et al. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 1995;92:1391-95.
30. Moulton KS, Wu H, Barnett J, Parathasarathy S, Glass CK. Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences. Proc Natl Acad Sci USA 1992;89: 8102-06.
31. Wu H, Moulton K, Horvai A, Parik S, Glass CK. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol 1994;14:2129-39.
32. de Villiers WJ, Fraser IP, Gordon S. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol Lett 1994;43:73-9.
33. Sidell N, Han SW, Parathasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 2002;955:159-73; discussion 199-200, 396-406.
34. Sharpe-Timms KL, Piva M, Ricke EA, Surewicz K, Zhang YL, Zimmer RL. Endometriosis synthesizes and secretes a haptoglobin-like protein. Biol Reprod 1998;58:988-94.
35. Piva M, Sharpe-Timms KL. Peritoneal endometriotic lesions differentially express a haptoglobin-like gene. Mol Hum Reprod 1999;5:71-8.
36. Sharpe-Timms KL, Zimmer RL, Ricke EA, Piva M, Horowitz GM. Endometriotic haptoglobin binds to peritoneal macrophages and alters their function in women with endometriosis. Fertil Steril 2002;78:810-19.
37. Kim JG, Keshava C, Murphy AA, Pitas RE, Parathasarathy S. Fresh Mouse peritoneal macrophages have low scavenger receptor activity. J Lipid Res 1997;38: 2207-15.
38. McLaren J, Prentice A, Charnock-Jones DS, Sharkey AM, Smith SK. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 1997;12:146-52.
39. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995;182:875-84.
40. Dmowski WP, Braun DP. Immunology of endometriosis. Best Pract Res Clin Obstet Gynecol 2004;18:245-63.
41. Kikuchi Y, Ishikava N, Hirata J, Imaizumi E, Sasa H, Nagata I. Changes of peripheral blood lymphocyte subsets before and after operation of patients with endometriosis. Acta Obstet Gynecol Scand 1993;72: 157-61.
42. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
43. Seli E, Berkkanoglu M, Arici A. Pathogensisi of endometriosis. Obstet Gynecol Clin N Am 2003;30: 41-61.
44. Gagne D, Rivard M, Page M, Shazand K, Hugo P, Gosselin D. Blood leukocyte subsets are modulated in patients with endometriosis. Fertil Steril 2003;80: 43-53.
45. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994;62:1086-88.
46. Ho HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997;38: 400-12.
47. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis:natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003; 9:223-8.
48. Wu MY, Yang JH, Chao KH, Hwang JL, Yang YS, Ho HN. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000;74:1187-91.
49. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T. Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002;77: 297-302.
50. Witz CA, Montoya IA, Dey TD, Schenken RS. Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am J Reprod Immunol 1994;32:173-79.
51. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981; 141:377-83.
52. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33-36.
53. Dmowski WP, Gebel HM, Braun DP. The role cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand 1994;159:7-l4.
54. Vigano P, Somigliana E, Di Blasio AM, Cozzolino S, Candiani M, Vignali M. Suppresion of natural killer cell function and production of soluble ICAM-1: endometrial stroma versus melanoma. Am J Reprod Immunol 2001;46:342-48.
55. Somigliana E, Vigano P, Gaffuri B, Guarneri D, Busacca M, Vignali M. Human endometrial stromal cells as a source of soluble intercellular adhesion molecule (ICAM)-1 molecules. Hum Reprod 1996;11:1190-94.
56. Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and proteins is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-56.
57. Garcia-Velasco JA, Arici A. Apoptosis and the pathogenesis of endometriosis. Semin Reprod Med 2003;21: 165-72.
58. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G. Macrophages derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999;5: 624-50.
59. Berkkanoglu M, Guzeloglu-Kayisli O, Kayisli UA, Selam BF, Arici A. Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro. Mol Hum Reprod 2004;10:393-8.
60. Selam B, Kayisli UA, Garcia-Velasco JA, Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod 2002;66:1-5.
61. Selam B, Kayisli UA, Garcia-Velasco JA, Akbas GE, Arici A. Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 2002;87:3921-27.
62. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996;2:40-5.
63. Garcia-Velasco JA, Mulayim N, Kayisli UA, Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril 2002;78:855-59.
64. Stratseva NV. Clinical immunological aspects of genital endometriosis. Akush Ginekol (Mosk) 1980;3:23-6.
65. Weed JC, Arquembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980;23:885-93.
66. Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982;50:259-66.
67. Gleicher N, el-Roeiy A, Confino E, Friberg J. Is endometriosis an autoimmune disease? Obstet Gynecol 1987;70:115-22.
68. Gleicher N, el-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376-80; discussion 1380-5.
69. Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repurcussions. J Clin Endocrinol Metab 1991;73:421-27.
70. Dmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, el-Roeiy A. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995;63:555-62.
71. Mathur SP. Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 2000;44:89-95.
72. Yeaman GR, Collins JE, Lang GA. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 2002;955:174-82.
73. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364: 1789-99.
74. Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol 2003;50:48-59.
75. Malinak LR, Buttram VC Jr, Elias S, Simpson JL. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol 1980; 137: 332-37.
76. Maxwell C, Kilpatrick DC, Haining R, Smith SK. No HLA-DR specifity is associated with endometriosis. Tissue Aantigens. 1989;34:145-47.
77. Isaacson KB, Coutifaris C, Garcia CR, Lyttle CR. Production and secretion of complement component 3 by endometriotic tissue. J Clin Endocrinol Metab 1989;69:1003-09.
78. Isaacson KB, Gamlan M, Coutifaris C, Lyttle CR. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril 1990;53:836-41.
79. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update 1996;2:385-98.
80. Chegini N. Peritoneal molecular environment, adhesion formation, and clinical implication. Front Biosci 2002; 1:e91-115.
81. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-26.
82. Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis: clinicopathological implications. Minerva Ginecol 2004;55:333-45.
83. Santanam N, Murphy AA, Parthasarthy S. Macrophages, oxidation, and endometriosis. Ann N Y Acad Sci 2001; 955:183-200.
84. Hill JA, Anderson DJ. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis. Am J Obstet Gynecol 1989;161;861-64.
85. Fakih H, Baggett B, Holtz G, Tsang KY, Lee JC, Williamson HO. Interleukin-1: possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-17.
86. Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26:62-7.
87. Lebovic DI, Bentzien F, Chao VA, Garett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukine-1. Mol Hum Reprod 2000;6:269-75.
88. Yoshioka H, Harada T, Iwabe T, Nagano Y, Taniguchi F, Tanikawa M et al. Menstrual cycle-specific inhibition of the proliferation of endometrial stromal cells by interleukin 6 and its soluble receptor. Am J Obstet Gynecol 1999;180:1088-94.
89. Rier SE, Zarmakoupis PN, Hu X, Becker JL. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlations with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 1995;80: 1431-37.
90. Arici A, Head J, MacDonald PC, Casey ML. Regulation of interleukin-8 gene expression in human endometrial cells in culture. Mol Cell Endocrinol 1993;94: 195-204.
91. Iwabe T, Harada T, Tsudo T, Tanikawa M, Onohara Y, Terakawa N. Pathogenic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998;69:924-30.
92. Arici A, Seli E, Zeyneloglu HB, Senturk LM, Oral E, Olive DL. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J Clin Endocrinol Metab 1998;83:1201-05.
93. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M et al. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab 2000;85:824-9.
94. Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM, Kingsland CR. Peritoneal fluid concentrations of IL-8 in women with endometriosis:relationship to stage of disease. Hum Reprod 1998;13:1957-616.
95. Garcia-Velasco JA, Arici A. Interleukin-8 stimulates the adhesion of endometrial stromal cells to fibronectin. Fertil Steril 1999;72:336-40.
96. Garcia-Velasco JA, Arid A. Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion. Mol Hum Reprod 1999;5: 1135-40.
97. Arici A. Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N Y Acad Sci 2002;955:101-09; discussion 118, 396-406.
98. Ulukus M, Ulukus EC, Seval Y, Zheng W, Arici A. Expression of interleukin-8 receptors in endometriosis. Hum Reprod 2005;24:794-801.
99. Arici A, Oral E, Attar E, Tazuke S, Olive DL. Monocyte chemotactic protein-1 concentration in peritoneal fluid in patients with endometriosis and its modulation in human mesothelial cells. Fertil Steril 1997;67: 1065-72.
100. Taketani T, Kuo TM, Mizuno M. Comparison of cytokine levels and embyo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992;167: 265-70.
101. Jolicoeur C, Boutouil M, Drouin R, Paradis I, Lemay A, Akoum A. Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis. Am J Pathol 1998;152:125-33.
102. Akoum A, Jolicoeur C, Boucher A. Estradiol amplifies interleukin-1 induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab 2000;85:896-904.
103. Barcz E, Kaminski P, Marianowski L. Role of cytokines in pathogenesis of endometriosis. Med Sci Monit 2000;6:1042-46.
104. Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV. Peritoneal fluid concentrations of cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993;169:1545-49.
105. Skarzynski DJ, Miyamoto Y, Okuda K. Production of prostoglandin f(2alpha) by cultured bovine endometrial cells in response to tumor necrosis factor alpha: cell type specifity and intracellular mechanisms. Biol Reprod 2000;62:1116-20.
106. Braun DP, Ding J, Dmowski WP. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil Steril 2002;78:727-32.
107. Cheong YC, Shelton JB, Laird SM, Richmond M, Kudesia G, Li TC et al. IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod 2002;17:69-75.
108. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-18.
109. Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus:rapid stimulation by estrogen correlates with estrogen-induced increase in uterine capillary permeability and growth. Endocrinology 1993;133:829-37.
110. McLaren J, Prentice A, Charnock-Jones DS, Millican KH, Sharkey AM, Smith SK. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996;98:482-9.
111. Donnez J, Smoes P, Gillerot S, Casana-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-90.